SET
0337
CBHB
0339
COLFORM
0341
4
RTECH
0342
5
SUNLOGY
0345
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.99%14.01B | 11.52%3.64B | 7.90%3.58B | 6.23%3.41B | 2.34%3.38B | -2.51%13.1B | -10.50%3.27B | -4.19%3.32B | 1.09%3.21B | 4.97%3.3B |
Net interest income | 4.37%9.45B | 4.76%2.41B | 5.29%2.41B | 4.86%2.32B | 2.57%2.32B | -1.22%9.06B | -6.41%2.3B | -4.27%2.29B | -0.32%2.21B | 7.37%2.26B |
-Total interest income | 4.61%18.87B | 2.48%4.79B | 2.49%4.72B | 5.91%4.7B | 7.81%4.67B | 20.82%18.04B | 10.92%4.67B | 19.31%4.6B | 26.71%4.44B | 28.80%4.33B |
-Total interest expense | 4.84%9.42B | 0.27%2.38B | -0.27%2.31B | 6.96%2.38B | 13.53%2.35B | 55.85%8.98B | 35.20%2.37B | 57.59%2.32B | 73.43%2.23B | 64.69%2.07B |
Non interest income | 12.85%4.56B | 27.62%1.23B | 13.69%1.17B | 9.25%1.09B | 1.82%1.06B | -5.29%4.04B | -18.94%965.53M | -4.00%1.03B | 4.35%1B | 0.13%1.04B |
-Total premiums earned | --29.19M | --29.19M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Fees and commissions | 12.16%2.19B | 10.51%538.69M | 14.06%572.62M | 13.23%541.25M | 10.81%534.47M | 1.85%1.95B | 3.22%487.46M | 8.38%502.03M | -0.77%478.02M | -3.01%482.33M |
-Including:Fees and commission income | 14.53%3.4B | 12.12%854.01M | 15.70%879.87M | 15.78%837.15M | 14.60%830.33M | 3.55%2.97B | 6.20%761.71M | 7.75%760.45M | -0.18%723.06M | 0.56%724.57M |
-Including:Fees and commission expense | 19.06%1.21B | 14.98%315.33M | 18.90%307.25M | 20.76%295.9M | 22.14%295.86M | 6.98%1.02B | 11.95%274.25M | 6.56%258.42M | 0.98%245.04M | 8.50%242.23M |
-Dividend income | 113.01%11.15M | 11,100.00%5.6M | 213.60%2.54M | 41.12%2.97M | -98.15%42K | 40.27%5.24M | -1.96%50K | -19.42%809K | 1.01%2.11M | 283.45%2.27M |
-Gain loss on sale of securities | 13.82%1.82B | 31.77%487.46M | 8.58%450.76M | 20.16%455.9M | -1.83%430.79M | -16.80%1.6B | -37.87%369.94M | -10.86%415.15M | -12.07%379.42M | 1.03%438.83M |
-Gain on investment properties | -240.32%-29.42M | -21.17%-15.07M | 816.67%330K | -491.47%-14.69M | ---- | -269.20%-8.65M | -296.83%-12.43M | 289.47%36K | 415.82%3.75M | ---- |
-Net reversal of impairment loss of financial instruments | 93.47%-273K | 114.85%809K | -149.74%-390K | -530.25%-1.02M | 35.51%332K | -250.27%-4.18M | -484.06%-5.45M | 76.98%784K | -78.81%238K | 220.69%245K |
-Total other operating income | 11.01%537.36M | 63.08%186.93M | 28.32%145.37M | -23.18%105.12M | -16.23%99.94M | 15.07%484.06M | -4.59%114.62M | -21.74%113.29M | 199.11%136.85M | 8.45%119.3M |
Credit losses provision | -100.43%-682K | -144.09%-42.4M | -162.64%-20.79M | -105.32%-1.31M | 2,112.62%63.81M | -57.09%156.84M | 7.04%96.17M | -65.33%33.18M | -69.21%24.6M | -97.12%2.88M |
Operating expense | 9.36%4.83B | 9.53%1.21B | 9.21%1.22B | 9.21%1.2B | 9.50%1.2B | 4.24%4.41B | 5.90%1.1B | 4.01%1.12B | 2.39%1.1B | 4.71%1.09B |
Staff costs | 11.10%3.55B | 11.09%892.29M | 11.08%901.43M | 9.79%871.57M | 12.47%885.77M | 5.01%3.2B | 7.27%803.23M | 5.37%811.48M | 3.60%793.86M | 3.82%787.58M |
Selling and administrative expenses | 4.28%417.62M | 11.20%105.51M | 7.79%108.46M | 0.53%100.47M | -1.78%103.17M | -5.92%400.48M | -5.38%94.89M | -11.72%100.62M | -13.07%99.94M | 8.91%105.04M |
-Selling and marketing expense | 12.00%122.98M | 37.53%32.23M | 15.38%32.73M | -3.40%29.1M | 3.75%28.92M | -1.25%109.81M | 4.61%23.44M | -9.64%28.37M | 2.08%30.13M | -0.05%27.88M |
-General and administrative expense | 1.36%294.63M | 2.56%73.28M | 4.81%75.73M | 2.23%71.37M | -3.77%74.25M | -7.56%290.68M | -8.25%71.45M | -12.51%72.25M | -18.30%69.81M | 12.56%77.16M |
Depreciation and amortization | -8.81%331.41M | -3.23%81.63M | -12.84%82.43M | -9.58%84.19M | -9.00%83.16M | -2.20%363.42M | -11.47%84.35M | 2.16%94.57M | 1.12%93.12M | -0.31%91.39M |
-Depreciation | -8.81%331.41M | -3.23%81.63M | -12.84%82.43M | -9.58%84.19M | -9.00%83.16M | -2.20%363.42M | -11.47%84.35M | 2.16%94.57M | 1.12%93.12M | -0.31%91.39M |
Insurance and claims | -0.32%25.81M | -10.40%6.07M | 0.30%6.25M | -1.45%6.24M | 10.61%7.25M | 1.70%25.89M | 8.09%6.78M | 2.28%6.23M | 7.98%6.33M | -9.43%6.55M |
Other operating expenses | 17.11%502.25M | 7.77%121.14M | 16.31%125.42M | 30.36%136.91M | 14.65%118.78M | 16.25%428.85M | 25.32%112.4M | 13.80%107.83M | 12.36%105.02M | 13.87%103.6M |
Income from associates and other participating interests | 1,172.23%241.16M | 471.17%73.93M | 2,716.55%78.95M | 2,097.86%74.07M | 8,988.13%14.22M | 172.87%18.96M | 82.35%12.94M | 112.83%2.8M | 1,269.92%3.37M | 90.67%-160K |
Special income (charges) | -12,893.25%-492.44M | -3,616.25%-480.21M | -390.43%-4.95M | -266.11%-6.75M | -115.81%-532K | 49.37%-3.79M | -173.83%-12.92M | 187.93%1.7M | 405.03%4.06M | 567.66%3.37M |
Less:Impairment of capital assets | 7,160.70%473.76M | 7,160.70%473.76M | ---- | ---- | ---- | --6.53M | --6.53M | ---- | ---- | ---- |
Less:Other special charges | 61.38%-587K | -225.49%-498K | 98.95%-12K | 135.98%59K | -122.95%-136K | 49.79%-1.52M | -45.71%-153K | -947.71%-1.14M | -41.38%-164K | 97.74%-61K |
Less:Write off | 1,686.01%19.27M | 6.12%6.95M | 982.74%4.96M | 271.58%6.69M | 120.22%668K | -111.56%-1.22M | 35.78%6.55M | -127.45%-562K | -369.27%-3.9M | -250.66%-3.3M |
Income before tax | 4.60%8.93B | 0.16%2.07B | 13.02%2.45B | 8.81%2.28B | -3.50%2.13B | -3.31%8.54B | -17.98%2.07B | -5.27%2.17B | 3.60%2.1B | 10.43%2.21B |
Income tax | 1.53%1.91B | -14.72%401.28M | 16.86%537.09M | 6.83%499.61M | -2.35%474.58M | -29.22%1.88B | -41.18%470.54M | -32.70%459.6M | -20.88%467.65M | -17.27%485.98M |
Net income | 5.47%7.02B | 4.55%1.67B | 11.99%1.91B | 9.38%1.78B | -3.82%1.66B | 7.87%6.66B | -7.20%1.6B | 6.41%1.71B | 13.71%1.63B | 21.96%1.72B |
Net income continuous operations | 5.47%7.02B | 4.55%1.67B | 11.99%1.91B | 9.38%1.78B | -3.82%1.66B | 7.87%6.66B | -7.20%1.6B | 6.41%1.71B | 13.71%1.63B | 21.96%1.72B |
Noncontrolling interests | -2,345.43%-127.97M | -606.36%-129.8M | -112.41%-719K | -113.27%-1.23M | -58.21%3.78M | -88.63%5.7M | -350.56%-18.38M | -58.43%5.79M | -36.70%9.24M | -36.60%9.04M |
Net income attributable to the company | 7.49%7.15B | 11.39%1.8B | 12.41%1.91B | 10.08%1.78B | -3.54%1.65B | 8.66%6.65B | -5.73%1.62B | 6.98%1.7B | 14.23%1.62B | 22.55%1.71B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 7.49%7.15B | 11.39%1.8B | 12.41%1.91B | 10.08%1.78B | -3.54%1.65B | 8.66%6.65B | -5.73%1.62B | 6.98%1.7B | 14.23%1.62B | 22.55%1.71B |
Gross dividend payment | ||||||||||
Basic earnings per share | 7.53%0.3684 | 11.66%0.0929 | 12.44%0.0985 | 10.07%0.0918 | -3.51%0.0852 | 8.66%0.3426 | -5.78%0.0832 | 6.96%0.0876 | 14.25%0.0834 | 22.47%0.0883 |
Diluted earnings per share | 7.53%0.3684 | 11.66%0.0929 | 12.44%0.0985 | 10.07%0.0918 | -3.51%0.0852 | 8.66%0.3426 | -5.78%0.0832 | 6.96%0.0876 | 14.25%0.0834 | 22.47%0.0883 |
Dividend per share | 42.86%0.2 | 0 | 11.11%0.1 | 0 | 100.00%0.1 | -28.93%0.14 | 0 | 12.50%0.09 | 0 | -35.06%0.05 |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.